← Back to Search

Maintaining Patency in Implanted Port Catheters

N/A
Waitlist Available
Led By Sarah Pelgen, BSN, RN, OCN
Research Sponsored by TriHealth Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a saline and heparin combo is better than saline alone for flushing implanted port catheters to prevent obstruction.

Eligible Conditions
  • Indwelling Catheter Complications
  • Catheter Obstruction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants With First Cathflo Administration for Occlusion (Blockage) Within 1 Year
Tubal Occlusion
Number of Participants With First Partial Occlusion Within 1 Year
Secondary study objectives
Number of Participants With First Complete or Partial Occlusion Within 1 Year
Number of Participants With HIT Within 1 Year

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Saline-only catheter flush - The intervention group will have their port catheters flushed with saline only.
Group II: Control GroupActive Control1 Intervention
Heparinized saline catheter flush - The control group will have their port catheters flushed with 20mL saline + 5mL heparin 100 units/mL; q 3 months

Find a Location

Who is running the clinical trial?

TriHealth Inc.Lead Sponsor
99 Previous Clinical Trials
53,387 Total Patients Enrolled
Sarah Pelgen, BSN, RN, OCNPrincipal InvestigatorTriHealth Cancer Institute
~34 spots leftby Dec 2025